The inducible shRNA and gRNA vectors were generated as previously described 1 . Optimized CRISPR Design -MIT (http://crispr.mit.edu) provided by the Zhang laboratory was used to design the gRNAs and that were subsequently cloned into the inducible vector pRSITEP-U6Tet-(sh)-EF1-TetRep-2A-Puro. To produce stable cell lines expressing Cas9, the constitutive lentiviral-based Cas9-mCherry vector was used, kindly provided by Marco Herold 2 . Cas9-mCherry positive cells were sorted on BD Fusion BSL2 and thereafter the cells were transduced with gRNA vectors expressing either iRFP670 or BFP. Real time PCR was used to determine the level of CRISPR-Cas9 knockout efficiency. Either forward or reverse PCR primers were designed to specifically anneal at the gRNA target sites. Primer pair specific for a non-coding locus upstream of the CHD4 gene was used as a normalization control. Genomic DNA from the CRISPR-Cas9 cells was isolated using QIAgen DNA extraction kit and 40 ug of DNA was used for the real time PCR. Primer sequences are available in Supplementary Table 3 .
Isolation of murine cKit + cells
To isolate cKit + cells, BM cells were collected from femur and tibias of C57BL/6 mice and lineage depletion of cells with committed lineages was achieved with Dynabeads (Invitrogen) by staining cells with purified antibodies for Ter119, B220, Gr1, CD3, Nk1.1, and CD11b (Biolegend). The fluorochrome-conjugated CD117 (cKit) antibody was used to sort cKit + cells by FACS Aria III (BD) (Supplementary Table 4 ). The dead cells were excluded by PI (Invitrogen).
Ethics Statement
Investigation has been conducted in accordance with the ethical standards and according to the Declaration of Helsinki and according to national and international guidelines and has been approved by the authors' institutional review board. The primary AML childhood BM samples were obtained from Uppsala biobank (reg.nr 827) after approval from NOPHO -Nordic Society of Paediatric Haematolgy and Oncology and the local ethical committee at Stockholm (ethical permit: 2017 Stockholm (ethical permit: -1059 . All procedures relating to animal experiments were approved by the local ethics committee in Linköping, Sweden and the Swedish board of agriculture (Ethical permit number; ID 530). UCB samples were obtained from the Karolinska Hospital (Stockholm, Sweden) with informed consent of the parents.
Transfection and Transduction
Transfection and transduction was performed as previously described 3 .
Large-scale shRNA screens
To ensure a recommended coverage >1000 transduced cells/shRNA, approximately 3×10 8 cells (THP-1, NOMO-1, FDCP-mix, murine AML) were cultured in concentration between 250,000 to 1,000,000 cells/mL and transduced with pooled barcoded lentiviral shRNA libraries targeting disease-associated genes (Module 2, Cellecta Inc). The transduction efficiency was determined by flow cytometry and kept below 25% to minimize the number of cells with multiple integrations of the vectors. 48 hours after selection with puromycin (2 µg/mL) (Invitrogen) when the selection control cells were dead, half of the cells were collected for an initial input control (T0). The remaining cells were propagated for 10 cell divisions (T10, to equalize for different cell division rates between the cell types). Thereafter, the genomic DNA was extracted by QIAgene DNA extraction kit according to the manufacturer's instructions, and the barcodes were amplified using nested PCR according to Cellecta's protocols. After purification using the QIAgene PCR purification kit, the barcodes were used for next generation sequencing (HiSeq 2000, Illumina) . The barcodes were deconvoluted using Cellecta's software and the number of reads for the barcodes was normalized between all samples. The ratios of the barcodes from the two screens were calculated by first dividing the normalized abundance of each barcode after T10, the abundance at the initial time point (T0) separately for each cell line. For calculating the ratios between the murine AML cells and the FDCP-mix cells the relative abundance of each barcode in the murine AML cells was divided with the corresponding barcode in the FDCP-mix control cells.
RNA extraction and quantitative real time PCR (qPCR)
RNA from sorted mouse hematopoietic cell fractions was extracted using RNeasy Micro Kit (Qiagen) and DNase, following the manufactures instructions. RNA concentration and quantity was determined by DNA/RNA/Protein analyzer (NanoDrop). cDNA synthesis was performed in 20 uL reaction buffer containing 500 ng of RNA by using cDNA synthesis kit (Fermentas). qPCR was performed using ABI Thermal Cycler and qPCR primers were purchased from Eurofins company (primers are presented in Supplementary Table 3 ).
Mice studies
All the mice were kept in a pathogen-free animal facility in Karolinska Institutet, Huddinge, Sweden. The C57BL/6 wild type mice and the NOD-scid IL2Rgnull-3/GM/SF, NSG-SGM3 mice were obtained from The Jackson Laboratory. All of the transplanted mice were investigated daily for symptoms of leukemogenesis and disease progression was monitored by complete blood tests.
The murine MLL-AF9 induced AML cells and mouse model was generated as previously described 43. In short, CD45.1 BM cKit+ cells from wild type C57BL/6 mice aged 6-8 weeks were transduced with a retroviral vector expressing the human MLL-AF9 fusion oncogene and serially re-plated in semisolid medium. Thereafter, individual colonies were isolated and expanded. After isolation of individual clones, the retroviral transduced cells (2x106) were transplanted via tail vein injection into sub-lethally radiated (600 cGy) C57BL/6 wild type mice. The transplanted mice were investigated daily for symptoms of leukemogenesis and disease progression was monitored by complete blood tests. After disease onset, the MLL-AF9 induced AML cells were harvested from femur and tibias of euthanized primary recipient mice and leukemic cells were analyzed and sorted by flow cytometry and expanded in RPMI media in presence of IL3 (10ng/mL) and 10% FBS. The generated MLL-AF9 AML cell lines were subsequently used for further transplantation experiments or in vitro experiments.
For the Kaplan-Meier survival analysis, wild type CD45.2 C57BL/6 mice aged six-12 weeks from The Jackson Laboratory were used for transplantation of murine MLL-AF9 AML cells. AML cells transduced with lentiviral shRNA vectors were selected with puromycin (2 µg/mL) and 250,000 AML cells were intravenously transplanted into non-irradiated recipient mice. After disease onset, the mice were euthanized. The experiments using humanized NSG-SGM3 mice were performed on animals aged six to ten weeks. Recipient mice were subjected to sub-lethal irradiation (220 Gy) and six to 12 hours post irradiation the primary childhood AML patient BM samples were transplanted via intra-femur injection using doses of 100,000-500,000 cells/mouse. BM samples were collected from the bones of euthanized primary recipient mice 6-8 weeks post transplantation and the primary leukemic cells were analyzed with flow cytometric analysis for donor cell engraftment (See Supplementary Table 4 for antibodies).
Apoptosis analysis
Briefly, THP-1 cells were washed with PBS and stained with Live/Dead Fixable Near IR dead cells stain (Thermo Fisher) for 20 minutes on ice. After washing the cells, they were washed once with Annexin-binding buffer (BioLegend) and then stained with Annexin V FITC (BioLegend) in Annexin-binding buffer for 20 minutes at 4 degrees. Washing, cells were resuspended in Annexin-binding buffer and analyzed by flow cytometric analysis.
Cell cycle analysis
THP-1 cells were washed with PBS and stained with Live/Dead Fixable Near IR dead cells stain for 20 minutes at 4 degrees and then washed with cold PBS. Then they were resuspended in 250 µL of fixation/permeabilization solution (BD) for 30 minutes at 4 degrees in dark. Then cells were washed with 1x wash buffer (BD) two times and pelleted cells were incubated in 10 µL of Ki67-FITC for 2 hours on ice in dark. After washing in cold PBS with 10% FCS, the cells were resuspended in DAPI at the concentration of 0.5 µg/mL in PBS+10% FCS for 20 minutes at room temperature, before being analyzed with FACS Fortessa LSRII (BD).
RNA-Sequencing
Total RNA was extracted from 2 x 103 FACS-sorted THP-1 cells by RNeasy Micro Kit (Qiagen), 72 hours after transduction of the cells, or by selection with puromycin. TotalScriptTM RNA-seq kit (Epicentre, Madison, WI) was used to prepare strand specific pair-end RNA libraries according to the manufacturer's instructions. Libraries were pair-end sequenced using the Illumina platform HiSeq2000 or Nextseq500. RNA-Seq reads were mapped to the Ensembl Homo_sapiens.GRCh38 reference genome using the STAR aligner. Gene assignment was performed using featureCounts. Normalization and the sample group comparison was performed using DESeq2. The RNA-Seq data (GSE106392) are available at: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE106392
Western Blotting
Total cellular proteins were extracted from cultured cells using RIPA Buffer, including Protease Inhibitor Cocktail (sc24948, Santa Cruz Biotechnology). 15-20 ug protein was prepared in NuPAGE reducing agent (NP0007, Invitrogen). Proteins were separated in 4-15% Tris Glycine gels (456-1084, Biorad) and transferred to nitrocellulose membranes (1704158, Biorad) by using Trans Blot Turbo Blotting System (170-4155, Biorad). Precision Plus Protein™ Dual Color Standards (1610374, Biorad) was used for molecular weight comparison of protein. Nitrocellulose membranes were blocked with 5% nonfat dried milk (170-6404, Biorad) dissolved in 1X PBS (D8537, Sigma) containing 0.2% Tween 20 (P9416, Sigma) at room temperature for 1 h and probed with primary antibodies against Mi-2 β/CHD4 (MABE 915 Milipore, 06-1306, Milipore) and Beta Actin (A5441, Sigma) overnight at 4 0C . Blots were incubated in secondary antibodies of goat anti-rabbit and antimouse IgG (H+L) horseradish peroxidase conjugated for 1 hour at room temperature (G21234, 31430, Thermo Scientific). The detection of proteins was performed by using enhanced chemiluminescence kit (32106, Thermo Scientific) and the image was captured by a LI-COR Odyssey Fc Imager system. Quantification of the relative intensity of the bands were performed by using Image Studio Lite (LI-COR Biosciences).
Statistical analysis
Statistic analysis was done with GraphPad Prism version 6 and P-values of <0.05 were considered statistically significant. t-tests were used to determine the statistical differences between groups. GSEA analysis was done using log2 transformed expression values and the Molecular Signature Data Base, MSigDB (http://software.broadinstitute.org/gsea/msigdb/annotate.jsp), applying "Compute Overlaps" tool and "Hallmark gene sets" and "Reactome gene sets". Figure 3A ), relative to control samples transduced with negative control vectors, at 72 hours post transduction. mRNA levels were normalized to UBC. The data is represented as the mean ±S.E.M., ****p<0.001 (unpaired t-test), n=3. B. Western blot analysis of CHD4 and Actin levels in the indicated cells, with and without knockdown of CHD4 (knockdown of protein levels of CHD4 in THP-1 cells used in this assay is depicted in Supplementary Figure 3B ). C-F. Flow cytometric quantification as the percentage of cells in each population of the indicated cell lines transduced with CHD4 shRNA or a control vector, at 72 hours post transduction. The data is presented as mean ±S.E.M., ns = non significant, **p<0.01, ***p<0.005, ****p<0.001 (unpaired t-test), n=3. G-J. Bar graphs illustrating flow cytometric quantification as the percentage of cells in each population of the indicated cell lines transduced with CHD4 shRNA or a control vector, at 72 hours post transduction. The data is presented as mean ±S.E.M., ns = non significant, *p<0.05, **p<0.01, ***p<0.005, (unpaired t-test), n=3. Real time PCR analysis of mRNA levels in THP-1 cells, after shRNA-based knockdown of CHD4 (shRNA 2), relative to control cells transduced with vectors expressing scrambled shRNA, at 72 hours post transduction. mRNA levels were normalized to UBC. The data is represented as the mean ±S.E.M., ns = non significant, **p<0.01, ***p<0.005, ****p<0.001, (unpaired t-test), n=3. D. Bar charts of real time PCR analysis of mRNA levels of genes showing changes in RNA-Seq of THP-1 cells, after shRNA-based knockdown of CHD4, relative to control cells transduced with vectors expressing scrambled shRNA, at 72 hours post transduction. mRNA levels were normalized to UBC. The data is represented as the mean ±S.E.M., ns = non-significant, *p<0.05, **p<0.01, ***p<0.005, ****p<0.001 (unpaired t-test), n=3. Supplementary Figure 8 A B 
